Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
74
1.470
Why?
Head and Neck Neoplasms
14
2012
285
1.240
Why?
Carcinoma, Squamous Cell
12
2011
330
0.840
Why?
Neck
7
2018
98
0.680
Why?
Vascular Malformations
3
2010
104
0.630
Why?
Head
5
2018
70
0.600
Why?
Terminal Care
1
2018
37
0.550
Why?
Patients
1
2018
50
0.550
Why?
Flow Cytometry
7
2024
397
0.550
Why?
Hemangioma
3
2018
85
0.530
Why?
Attitude to Health
1
2018
191
0.520
Why?
Laryngectomy
3
2013
27
0.510
Why?
Laryngeal Neoplasms
2
2007
44
0.480
Why?
Quality of Life
3
2012
878
0.450
Why?
Carcinoma, Merkel Cell
4
2016
41
0.440
Why?
Laser Therapy
3
2011
76
0.440
Why?
Laryngeal Diseases
1
2013
12
0.390
Why?
Nuclear Proteins
6
2015
246
0.390
Why?
Herpes Simplex
1
2013
25
0.390
Why?
Parotid Diseases
1
2012
3
0.390
Why?
Neuromuscular Agents
1
2012
8
0.390
Why?
Botulinum Toxins, Type A
1
2012
14
0.380
Why?
Leukoplakia, Oral
1
2011
6
0.370
Why?
Aminolevulinic Acid
1
2011
8
0.370
Why?
Lasers, Dye
1
2011
10
0.360
Why?
Eating
1
2012
159
0.360
Why?
Photosensitizing Agents
1
2011
19
0.360
Why?
Photochemotherapy
1
2011
31
0.360
Why?
Survivors
1
2012
118
0.350
Why?
Photoacoustic Techniques
2
2024
24
0.350
Why?
Female
30
2024
28055
0.340
Why?
Humans
49
2024
52114
0.340
Why?
Neoplastic Cells, Circulating
4
2019
34
0.340
Why?
Middle Aged
21
2024
13028
0.330
Why?
Male
30
2024
26652
0.330
Why?
Cheek
1
2010
9
0.320
Why?
Pain
1
2012
353
0.320
Why?
Lip
1
2010
11
0.320
Why?
Facial Neoplasms
1
2010
22
0.320
Why?
Adult
21
2024
14095
0.310
Why?
Receptors, Progesterone
1
2009
66
0.310
Why?
Aged
16
2018
10142
0.300
Why?
Postoperative Complications
3
2012
1071
0.300
Why?
Lymphatic Vessels
1
2009
44
0.300
Why?
Skin Neoplasms
4
2016
499
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1020
0.290
Why?
Neoplasms
1
2018
1288
0.280
Why?
Surgical Flaps
1
2009
110
0.280
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.280
Why?
Laryngeal Nerves
1
2007
15
0.280
Why?
Melanoma
2
2022
278
0.270
Why?
Erythrocytes
2
2024
70
0.270
Why?
Factor VII
1
2007
3
0.270
Why?
Intracranial Arteriovenous Malformations
1
2007
32
0.260
Why?
Dilatation
2
2017
25
0.250
Why?
Malaria
2
2024
37
0.240
Why?
Adolescent
11
2024
6681
0.230
Why?
Gene Silencing
4
2009
120
0.220
Why?
Disease Models, Animal
3
2016
1467
0.220
Why?
Cell Proliferation
4
2016
1017
0.200
Why?
Melanoma, Experimental
2
2016
34
0.200
Why?
Retrospective Studies
10
2015
6610
0.200
Why?
Immunohistochemistry
8
2014
975
0.200
Why?
Treatment Outcome
7
2018
5456
0.190
Why?
Promoter Regions, Genetic
7
2015
465
0.190
Why?
Muscarinic Agonists
1
2002
10
0.190
Why?
Xerostomia
1
2002
4
0.190
Why?
Sjogren's Syndrome
1
2002
13
0.190
Why?
Endoscopy
2
2015
123
0.190
Why?
Plasmodium yoelii
1
2022
12
0.190
Why?
Thiophenes
1
2002
46
0.190
Why?
Nitric Oxide Synthase Type III
2
2013
82
0.190
Why?
Quinuclidines
1
2002
39
0.180
Why?
Transcription Factors
2
2015
564
0.180
Why?
Embolization, Therapeutic
3
2011
89
0.170
Why?
Veins
3
2010
74
0.170
Why?
Azepines
3
2016
21
0.170
Why?
Triazoles
3
2016
113
0.160
Why?
Child
10
2012
7147
0.160
Why?
Neoplasm Invasiveness
3
2010
277
0.150
Why?
Child, Preschool
8
2012
4001
0.150
Why?
Mast Cells
1
2018
55
0.140
Why?
Mice
10
2022
5877
0.140
Why?
Combined Modality Therapy
4
2018
634
0.140
Why?
Ki-67 Antigen
3
2013
58
0.140
Why?
Cricoid Cartilage
1
2017
10
0.140
Why?
Estradiol
1
2018
217
0.130
Why?
Trachea
1
2017
53
0.130
Why?
Mice, Nude
5
2016
231
0.130
Why?
Follow-Up Studies
3
2011
2282
0.130
Why?
Infant
7
2018
3660
0.130
Why?
Biopsy
3
2015
599
0.130
Why?
Lasers, Semiconductor
2
2022
7
0.130
Why?
Embolism
1
2016
18
0.130
Why?
Neoplasm Staging
2
2010
766
0.120
Why?
Benzoxazoles
1
2016
11
0.120
Why?
Matrix Metalloproteinase 2
1
2016
58
0.120
Why?
Qualitative Research
1
2018
358
0.120
Why?
Matrix Metalloproteinase 9
1
2016
87
0.120
Why?
Tracheotomy
1
2015
15
0.120
Why?
TOR Serine-Threonine Kinases
1
2016
82
0.120
Why?
Tracheal Stenosis
1
2015
13
0.120
Why?
Laryngostenosis
1
2015
12
0.120
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
Why?
Aged, 80 and over
6
2015
3382
0.120
Why?
Larynx
2
2017
30
0.110
Why?
Pyrimidines
1
2016
198
0.110
Why?
Disease Progression
3
2014
866
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2014
53
0.110
Why?
Fluorouracil
2
2004
57
0.110
Why?
Gene Expression Regulation, Neoplastic
3
2015
853
0.110
Why?
Carcinoma
2
2012
136
0.110
Why?
DNA Methylation
5
2009
583
0.110
Why?
Breast Neoplasms
2
2015
1199
0.100
Why?
Apoptosis
2
2016
1117
0.100
Why?
Plasmodium falciparum
2
2024
23
0.100
Why?
Animals
10
2022
13332
0.100
Why?
Mastication
1
2012
5
0.100
Why?
Trismus
1
2012
2
0.100
Why?
DNA, Neoplasm
2
2011
146
0.100
Why?
Adaptor Proteins, Signal Transducing
3
2009
198
0.100
Why?
Cisplatin
2
2004
284
0.090
Why?
Radiotherapy, Adjuvant
1
2012
63
0.090
Why?
Receptors, Cell Surface
1
2013
110
0.090
Why?
Recurrence
2
2011
680
0.090
Why?
Lymphangioma, Cystic
1
2011
10
0.090
Why?
Cross-Sectional Studies
3
2024
1665
0.090
Why?
Chemoradiotherapy
1
2012
49
0.090
Why?
Endothelium, Lymphatic
1
2011
8
0.090
Why?
Syndrome
1
2012
247
0.090
Why?
Antigens, CD
1
2013
215
0.090
Why?
Administration, Topical
1
2011
60
0.090
Why?
Epigenesis, Genetic
1
2015
401
0.090
Why?
Propranolol
1
2012
77
0.090
Why?
Lymphatic Abnormalities
1
2011
20
0.090
Why?
Microtubule-Associated Proteins
1
2011
61
0.090
Why?
Immunoenzyme Techniques
4
2016
135
0.090
Why?
Enteral Nutrition
1
2012
153
0.090
Why?
Deglutition Disorders
1
2012
76
0.090
Why?
Homeodomain Proteins
1
2011
80
0.090
Why?
Brain Neoplasms
1
2014
287
0.090
Why?
Diagnosis, Differential
2
2011
1031
0.090
Why?
Tumor Suppressor Proteins
1
2011
128
0.090
Why?
Weight Gain
1
2012
244
0.080
Why?
Risk Assessment
1
2015
1339
0.080
Why?
Epigenomics
1
2011
74
0.080
Why?
Xenograft Model Antitumor Assays
3
2016
216
0.080
Why?
Diagnostic Imaging
1
2011
172
0.080
Why?
Neoplasm Proteins
2
2003
328
0.080
Why?
Lip Neoplasms
1
2010
3
0.080
Why?
Neoplastic Stem Cells
1
2011
90
0.080
Why?
Neoplasm Recurrence, Local
2
2019
630
0.080
Why?
Hospitals, Teaching
1
2010
52
0.080
Why?
Neoadjuvant Therapy
1
2011
123
0.080
Why?
Survival Rate
3
2011
945
0.080
Why?
Lasers, Solid-State
1
2010
31
0.080
Why?
Medical Records
1
2010
86
0.080
Why?
Microsatellite Instability
1
2009
21
0.080
Why?
Vascular Surgical Procedures
1
2011
166
0.080
Why?
Melanins
1
2009
20
0.080
Why?
Mouth
1
2010
33
0.080
Why?
Young Adult
3
2024
4307
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Pilot Projects
1
2011
712
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.070
Why?
Immunotherapy
1
2011
240
0.070
Why?
Receptors, Estrogen
1
2009
131
0.070
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
24
0.070
Why?
Port-Wine Stain
1
2008
14
0.070
Why?
Muscle, Smooth, Vascular
1
2009
135
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1368
0.070
Why?
Blotting, Western
3
2016
588
0.070
Why?
Thyroid Neoplasms
1
2009
113
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
187
0.070
Why?
Cytokines
1
2011
621
0.070
Why?
Early Detection of Cancer
2
2022
183
0.070
Why?
Tumor Cells, Cultured
3
2016
445
0.070
Why?
Factor VIIa
1
2007
8
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Practice Guidelines as Topic
1
2010
494
0.070
Why?
Infant, Newborn
2
2011
2859
0.070
Why?
Practice Management, Medical
1
2006
9
0.060
Why?
Osteonecrosis
1
2007
35
0.060
Why?
Postoperative Hemorrhage
1
2007
54
0.060
Why?
Tongue
1
2007
40
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Cell Line, Tumor
3
2015
1418
0.060
Why?
Diphosphonates
1
2007
92
0.060
Why?
Otolaryngology
1
2006
61
0.060
Why?
Prospective Studies
1
2011
2424
0.060
Why?
Recombinant Proteins
1
2007
492
0.060
Why?
Skin
1
2008
418
0.060
Why?
Mice, Inbred NOD
2
2016
90
0.060
Why?
Mice, SCID
2
2016
178
0.060
Why?
Cameroon
1
2024
2
0.060
Why?
Hemeproteins
1
2024
4
0.060
Why?
Parasitemia
1
2024
6
0.060
Why?
Neoplasm Metastasis
2
2015
236
0.060
Why?
Malaria, Falciparum
1
2024
21
0.060
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.050
Why?
DNA Repair Enzymes
1
2004
43
0.050
Why?
Ataxia Telangiectasia
1
2004
6
0.050
Why?
Statistics, Nonparametric
1
2004
196
0.050
Why?
ROC Curve
1
2024
250
0.050
Why?
Polymerase Chain Reaction
4
2009
460
0.050
Why?
Genes, p16
1
2003
9
0.050
Why?
Lymph Node Excision
1
2004
133
0.050
Why?
Radiotherapy
1
2004
128
0.050
Why?
Magnetic Resonance Angiography
2
2018
67
0.050
Why?
Magnetic Resonance Imaging
2
2007
1518
0.050
Why?
Proteoglycans
1
2003
86
0.050
Why?
Antigens, Nuclear
2
2013
24
0.050
Why?
Transplantation, Heterologous
2
2013
78
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
580
0.050
Why?
Sensitivity and Specificity
1
2024
871
0.050
Why?
Longitudinal Studies
1
2024
742
0.050
Why?
Membrane Glycoproteins
1
2003
238
0.050
Why?
Double-Blind Method
1
2002
718
0.040
Why?
Survival Analysis
3
2009
667
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Arkansas
1
2004
2016
0.040
Why?
Estrogen Receptor beta
1
2018
54
0.040
Why?
Estrogen Receptor alpha
1
2018
85
0.040
Why?
Protein Transport
1
2018
166
0.040
Why?
Ultrasonography, Doppler
1
2018
41
0.030
Why?
Biopsy, Fine-Needle
2
2009
104
0.030
Why?
Cadaver
1
2017
90
0.030
Why?
Pressure
1
2017
102
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Serum
1
2016
32
0.030
Why?
Risk Factors
3
2015
3922
0.030
Why?
Drug Synergism
1
2016
148
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
19
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
182
0.030
Why?
Acetylation
1
2015
96
0.030
Why?
Enhancer Elements, Genetic
1
2015
59
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
97
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
17
0.030
Why?
Drug Therapy, Combination
1
2016
399
0.030
Why?
Prognosis
3
2004
2093
0.030
Why?
Chromatin
1
2015
141
0.030
Why?
Cell Cycle Proteins
1
2015
167
0.030
Why?
HEK293 Cells
1
2014
231
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
38
0.030
Why?
Gene Expression Regulation
1
2018
1000
0.030
Why?
Comorbidity
1
2015
628
0.030
Why?
Protein Binding
1
2015
665
0.030
Why?
Down-Regulation
1
2014
343
0.030
Why?
Actins
1
2013
117
0.020
Why?
RNA, Messenger
1
2016
1135
0.020
Why?
Base Sequence
2
2004
627
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Predictive Value of Tests
1
2014
939
0.020
Why?
Cell Line
1
2014
1018
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Tissue Culture Techniques
1
2011
42
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Graft Survival
1
2011
158
0.020
Why?
Indomethacin
1
2011
36
0.020
Why?
Gene Expression Profiling
1
2016
1101
0.020
Why?
Injections, Subcutaneous
1
2011
51
0.020
Why?
Interleukin-2
1
2011
68
0.020
Why?
Carrier Proteins
2
2003
316
0.020
Why?
Time Factors
2
2007
2970
0.020
Why?
Cyclophosphamide
1
2011
173
0.020
Why?
Interferon-gamma
1
2011
172
0.020
Why?
Interleukin-1beta
1
2011
87
0.020
Why?
Drug Administration Schedule
1
2011
374
0.020
Why?
Disease-Free Survival
1
2011
462
0.020
Why?
Glottis
1
2010
34
0.020
Why?
Endothelial Cells
1
2011
281
0.020
Why?
Sclerotherapy
1
2010
47
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
392
0.020
Why?
Thyroidectomy
1
2009
61
0.020
Why?
Paraffin Embedding
1
2008
52
0.020
Why?
Mice, Transgenic
1
2009
560
0.020
Why?
Signal Transduction
1
2014
1699
0.020
Why?
Curettage
1
2007
13
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
10
0.020
Why?
Hyperbaric Oxygenation
1
2007
15
0.020
Why?
Collateral Circulation
1
2007
38
0.020
Why?
Pharyngeal Diseases
1
2007
12
0.020
Why?
Current Procedural Terminology
1
2006
10
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
14
0.020
Why?
Neck Dissection
1
2007
29
0.020
Why?
Angiography
1
2007
115
0.020
Why?
Office Visits
1
2006
44
0.020
Why?
Fistula
1
2007
27
0.020
Why?
Salvage Therapy
1
2007
136
0.020
Why?
Genetic Predisposition to Disease
1
2009
528
0.020
Why?
Imidazoles
1
2007
123
0.020
Why?
Adrenal Cortex Hormones
1
2007
114
0.020
Why?
Preoperative Care
1
2007
174
0.010
Why?
Ultrasonography
1
2006
420
0.010
Why?
United States
1
2015
5168
0.010
Why?
Guanine
1
2004
40
0.010
Why?
DNA Adducts
1
2004
79
0.010
Why?
Methylation
1
2004
126
0.010
Why?
Syndecans
1
2003
37
0.010
Why?
Syndecan-1
1
2003
73
0.010
Why?
Base Pair Mismatch
1
2003
21
0.010
Why?
Cell Count
1
2003
143
0.010
Why?
Antineoplastic Agents
1
2011
1214
0.010
Why?
DNA Repair
1
2003
194
0.010
Why?
Alcohol Drinking
1
2003
236
0.010
Why?
Molecular Sequence Data
1
2003
766
0.010
Why?
Anti-Bacterial Agents
1
2007
796
0.010
Why?
Smoking
1
2003
516
0.010
Why?
Multiple Myeloma
1
2007
2999
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description